We Need CURE ID— A tool for reporting new uses of existing drugs is valuable!

Submit a public comment to tell FDA you want to see cures/treatments for Long COVID prioritized in drug repurposing

To address the escalating Long COVID crisis, we need everyone to ask the FDA to prioritize drug repurposing for chronic illnesses following infectious diseases such as COVID-19. Let them know that you find it odd that CURE ID - FDA’s primary repurposing initiative - is not mentioned in its request for drug repurposing info for unmet medical needs. 

Based on the latest surveillance report, 1 in 6 infected with COVID-19 developed this multi-systemic condition that’s currently incurable and mass disabling the workforce in the United States. 89.31% of these patients had at least 1 chronic condition. (JAMA Network, 2026). 

We need the FDA to expedite the approval of repurposed drugs for treating Long COVID and significantly expand the CURE ID program. A tool for reporting new uses of existing drugs is valuable. We need ‘CURE ID’.

Template available in our Health Justice Toolkit. The deadline for comments is June 11. You can submit your comment here.

(Note docket number FDA-2026-N-4492 for “Drug Repurposing for Unmet Medical Needs; Request for Information.”)

Comment Template   Submit your comment